An introduction to insulin pump therapy

Nicholls, Adam R.; Partridge, Helen

doi:10.1002/psb.1315

The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.

Prescriber

2015

DOI: 10.1002/psb.1315

|View full text |Cite

An introduction to insulin pump therapy

Adam R. Nicholls¹,

Helen Partridge²

Abstract: Insulin pump therapy currently seems to be reserved for the few, yet many more type 1 diabetes patients could benefit from this delivery system. This review outlines the evidence for insulin pumps including patient selection and suggests more could be done to initiate their use.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2015

2017

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Continuous subcutaneous insulin infusion in patients with type 1 disease

Meetoo

Wong

Fatani

2017

British Journal of Healthcare Management

View full text Add to dashboard Cite

Optimal blood glucose control and the restoration of physiological insulin secretion is an ongoing medical challenge. Continuous subcutaneous insulin infusion (CSII) aims to restore blood glucose levels and reduce the frequency of hypoglycaemic events. Its benefits include a better glycaemic profile compared with management involving multiple daily insulin injections and giving individuals more flexibility in their everyday lives. The advantages of insulin pumps include basal delivery consistency, adjustable basal rates and low insulin depots. However, experience with CSII indicates that candidates should be selected carefully, be well educated in how use the device and be highly motivated to improve their blood glucose control.

show abstract

Continuous subcutaneous insulin infusion in patients with type 1 disease

Meetoo

Wong

Fatani

2017

British Journal of Healthcare Management

View full text Add to dashboard Cite

show abstract

Why recommend insulin pumps?

Morris

2015

Independent Nurse

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

An introduction to insulin pump therapy

Abstract: Insulin pump therapy currently seems to be reserved for the few, yet many more type 1 diabetes patients could benefit from this delivery system. This review outlines the evidence for insulin pumps including patient selection and suggests more could be done to initiate their use.

Cited by 2 publications

References 6 publications

Continuous subcutaneous insulin infusion in patients with type 1 disease

Continuous subcutaneous insulin infusion in patients with type 1 disease

Why recommend insulin pumps?

Contact Info

Product

Resources

About